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Background: Determining an animal’s genetic merit using genomic information can improve estimated breeding
value (EBV) accuracy; however, the magnitude of the accuracy improvement must be large enough to recover the
costs associated with implementing genome-enabled selection. One way to reduce costs is to genotype nucleus
herd selection candidates using a low-density chip and to use high-density chip genotyping for animals that are
used as parents in the nucleus breeding herd. The objective of this study was to develop a tool to estimate the cost
structure associated with incorporating genome-enabled selection into multi-level commercial breeding programs.
Results: For the purpose of this deterministic study, it was assumed that a commercial pig is created from a
terminal line sire and a dam that is a cross between two maternal lines. It was also assumed that all male and
female selection candidates from the 1000 sow maternal line nucleus herds were genotyped at low density and all
animals used for breeding at high density. With the assumptions used in this analysis, it was estimated that
genome-enabled selection costs for a maternal line would be approximately US$0.082 per weaned pig in the
commercial production system. A total of US$0.164 per weaned pig is needed to incorporate genome-enabled
selection into the two maternal lines. Similarly, for a 600 sow terminal line nucleus herd and genotyping only male
selection candidates with the low-density panel, the cost per weaned pig in the commercial herd was estimated
to be US$0.044. This means that US$0.21 per weaned pig produced at the commercial level and sired by boars
obtained from the nucleus herd breeding program needs to be added to the genetic merit value in order to break
even on the additional cost required when genome-enabled selection is used in both maternal lines and the
terminal line.
Conclusions: By modifying the input values, such as herd size and genotyping strategy, a flexible spreadsheet
tool developed from this work can be used to estimate the additional costs associated with genome-enabled
selection. This tool will aid breeders in estimating the economic viability of incorporating genome-enabled
selection into their specific breeding program.Background
The common method to estimate breeding values and rank
animals based on genetic merit is known as traditional
BLUP (best linear unbiased prediction) selection. Traditional
BLUP selection relies on phenotypic information measured
directly on selection candidates and their relatives to predict
the genetic merit for all animals. If molecular information is
included in the selection program, historically it would have
been in the form of marker-assisted selection for which only
a few markers are used [1].* Correspondence: stalder@iastate.edu
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When breeders incorporate the variation from genomic in-
formation into a selection strategy, it is known as genome-
enabled selection. This information is used to enhance
traditional breeding value estimation. Estimating an ani-
mal’s genetic merit at the molecular level may improve es-
timated breeding value (EBV) accuracy [2]. This improved
accuracy could further increase the rate of genetic gain for
the population. Traits that are lowly heritable, difficult to
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provement when using genome-enabled breeding value es-
timation compared to traits that can be directly measured
on all the candidates before selection.
Using a low-density marker panel can be an effective
method to reduce genotyping costs once the initial dataset
has been established. An initial population is needed to
determine population haplotypes so that imputation can
be used to infer genotypes from a low-density marker
panel. Inferring high-density genotypes from a low-density
panel is known as imputation [3]. When imputation is
used, selection candidates are genotyped using low-density
panels and the actual selected animals are commonly re-
genotyped using a high-density marker panel. To further
reduce costs, companies may choose to genotype only
males. While this saves costs, genomic EBV accuracy for
genotyped animals may be reduced, especially for sex-
limited or novel traits for which phenotypic data are not
routinely collected.
The objective of this study was to develop a tool to esti-
mate the cost structure associated with incorporating
genome-enabled selection into commercial breeding pro-
grams. Estimating an animal’s genetic merit using genomic
information can improve the accuracy of EBV; however,
this improved accuracy should be large enough to recover
the costs associated with implementing genome-enabled
selection.
Methods
Most commercial market hogs are the offspring from a
mating between a female that is a cross between two ma-
ternal lines and a male that is from a terminal line. The
three lines can be purebred, synthetic, or some composite
of the same type. Therefore, each maternal line contrib-
utes 25% of the genetic material to commercial animals,
and the terminal line makes up the other 50%. One mater-
nal line is typically derived from a Landrace population,
while the other maternal line is usually derived from a
Large White population. The terminal line is often derived
from a Duroc population. Each maternal line nucleus was
assumed to have 1000 sows while the terminal nucleus
had 600 sows. All three lines must be selected for im-
proved performance at the commercial level, and thus,
EBV must be estimated for each line. The terminal line is
typically selected based on a terminal sire index that can
consist of growth, meat quality, and carcass traits. The
maternal lines are often selected based on a maternal line
index, which comprises reproductive traits that are more
heavily emphasized in the index and some terminal mar-
ket traits.
Initial costs
When considering the costs associated with genome-
enabled selection, one has to consider not only thegenotyping costs, but also other ancillary expenses. In
the present analysis, genotyping costs were assumed to be
US$115 and US$55 for the high- and low-density panels,
respectively. These costs include the cost of the genotyp-
ing and all other costs associated with sample collection,
DNA isolation and storage, shipping, etc. Genotyping
costs will vary depending on the number of animals geno-
typed and the company used. Additionally, genotyping
costs will change (increase or decrease) as new tests be-
come available. For each of the three lines, it was assumed
that the initial data consisted of 2000 ancestor animals
that were genotyped using the high-density marker panel.
Developing genome-enabled EBV requires more time
and computing power compared to traditional BLUP EBV.
For this analysis, it was assumed that eight months were re-
quired to analyze the initial dataset and develop the pro-
gram that will be implemented for genetic evaluations.
Based on personal communications with a large swine gen-
etics company, an additional 8 hours was assumed to be
needed with each weekly evaluation to prepare data and to
ensure the program runs without errors. It was assumed
that the EBV development and additional weekly work
would cost US$60/hour in employee wages and benefits.
A US$50 000 investment was assumed for computing in-
frastructure. This cost includes equipment and labor associ-
ated with set-up. For this study, the infrastructure cost was
distributed across the three lines included in the breeding
program based on the relative proportion of nucleus sows
in each line. For this analysis, it was assumed that the costs
of the investment are expected to be recovered within three
years. In other words, a three-year planning horizon was as-
sumed. The infrastructure costs were assumed to have no
salvage value at the end of the planning horizon. A 5% dis-
counting rate [4] was used to calculate the present value of
the nominal annual costs associated with genome-enabled
selection.
When assessing cost structure within a genome-enabled
selection program, the infrastructure costs are nominal
relative to the annual genotyping costs. Therefore, a longer
planning horizon would not greatly impact the total an-
nual costs associated with incorporating genome-enabled
selection into the breeding program. A longer planning
horizon would allow accumulated genetic improvement in
multiple generations to help offset the additional costs.
Annual costs
Once an initial dataset has been collected and analyzed,
routine genotype collection can be scheduled for selection
candidates within each line in the breeding program. All
the offspring produced from the nucleus breeding herd
are potential selection candidates. The number of poten-
tial selection candidates and the genetic sampling will de-
termine how many selection candidates in a given year
must be genotyped. For this analysis, all male and female
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low density and then all animals used for actual breed-
ing were re-genotyped at high density in both maternal
lines. While genotyping both males and females is optimal
for increased annual genetic gain and reduced inbreeding,
it is not required to obtain genetic improvement using
genome-enabled selection [5]. Only male selection candi-
dates were genotyped for the terminal line, and boars
selected to become sires within the nucleus were re-
genotyped at high density. Only males are genotyped in
the terminal line since most terminal line selection indices
do not include sex-limited traits, reducing the value of
genotyping females. This genotyping scheme is represen-
tative of the strategy currently implemented in the swine
industry. Another way to reduce the annual genotyping
costs would be to genotype only a proportion of available
male and/or female selection candidates. Henryon et al.
[6] showed that only 5 to 20% of the selection candidates
must be genotyped in order to capture most of the genetic
gain realized from genotyping all of the selection candi-
dates. The animals to be genotyped could be preselected
based on their genetic potential estimated using traditional
BLUP methods [7].
Nucleus production
Genetic suppliers have different marketing schemes. Reve-
nues are obtained by selling boars, selling semen doses, or
charging weaned pig fees. However, a weaned pig fee can
be converted into the price of a dose or boar based on
how many commercial weaned pigs are produced by nu-
cleus boars. For the maternal lines, it was assumed that,
on average, each litter in the nucleus herd consisted of 11
pigs born alive [8] with a 1:1 sex ratio [9]. Each sow was
assumed to have 2.3 litters a year, on average [8]. The
combined pre-weaning and nursery mortality was as-
sumed to be 12% [8]. These assumptions result in 22 264
animals (1000 sows × 2.3 litters × 11 pigs × 0.88 survival;
11 132 males and 11 132 females) to be genotyped annu-
ally at low density in each maternal line. With 5% and 20%
selection for males and females [10], respectively, 557
males (11 132 × 0.05) and 2226 females (11 132 × 0.20) will
be re-genotyped with the high-density panel annually in
each maternal line. These represent the number of ani-
mals selected, but not all animals will be successful, repro-
ductive members of the breeding herd.
The average sow production in the terminal line nucleus
herd was assumed to be 10 pigs born alive per litter with a
1:1 sex ratio [9] and 2.1 litters per sow per year [8]. The
total mortality through the nursery was assumed to be
12%, as for the maternal lines. This means that 5544 male
pigs are produced and genotyped at low density in the ter-
minal line nucleus herd, annually. Assuming 5% male
selection, 277 males would be re-genotyped with a high-
density panel.The top 5% of the boars produced in the nucleus herd
based on genome-enabled EBV are assumed to be used as
nucleus replacements in the maternal and terminal lines.
The top 60% of male candidates in the sire line were used
in the commercial production system for the terminal line.
Boars were assumed to produce 25 semen doses weekly
with 15% of doses being discarded due to semen quality is-
sues [11]. It was assumed that 25% of selected boars would
not reach production due to infertility, disease, etc. All
boars used for reproduction within the nucleus or at the
commercial level were assumed to be used to maximum
capacity, meaning that all doses that are not discarded are
used for insemination. This means that 461 282 and 2 756
754 doses were produced annually from the maternal line
boars and terminal line boars, respectively. For example,
the annual doses produced in a terminal line would be cal-
culated as 5544 selection candidates × 75% productive ×
60% used × 25 doses per week × 85% viable semen × 52
weeks. This formula assumes that the boars have an aver-
age production life of one year.
The total number of weaned pigs produced each year
from the semen doses collected was calculated as 1 940
845 and 10 544 584 for the maternal and terminal lines,
respectively. The number of total weaned pigs produced
each year was calculated by multiplying the expected
number of litters by the number of pigs weaned in a litter.
This was based on 10% pre-weaning mortality in the com-
mercial herd, two doses of semen per sow serviced, and an
85% farrowing rate for commercial sows with 10 and 11
pigs born alive per litter in the terminal and maternal
lines, respectively [8]. For example, the number of weaned
pigs produced from the terminal boars was calculated as
2 756 754 doses / 2 doses per service × 85% farrowing
rate × 10 pigs/litter × 90% survival to weaning. For the ma-
ternal lines, 40% of the gilts developed were assumed to
never produce a litter [12], and for the sows that farrowed
at least one litter, it was assumed that each sow produced
35 weaned pigs per lifetime, on average [8]. For this study,
it was assumed that the commercial producers would have
an internal multiplication program for replacement gilts,
and thus, genetic improvement at the commercial level
would be realized through purchasing semen doses and/or
boars from the genetic supplier.
A spreadsheet was developed to calculate the total
estimated costs associated with incorporating genome-
enabled selection into a swine breeding program. The
spreadsheet can calculate the accumulated costs for up to
six different genetic lines that could be used to create a
commercial animal. The nucleus herd size and nucleus
production levels (i.e. number born alive, litters per sow
per year, mortality, and boar production) can be changed
to reflect the production system of the user. Which selec-
tion candidates are sampled on an annual basis can be al-
tered to depict the strategy that the company anticipates
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additional phenotyping costs associated with a novel trait
being added to the selection criteria. Additionally, the
spreadsheet can account for a multiplication factor if the
genetic supplier has a multiplication level within their
system.
Results and discussion
The total start-up cost was US$326 031 for both mater-
nal lines and US$318 338 for the terminal line. This
includes the costs associated with developing the genome-
enabled EBV and the genotyping of the initial dataset. The
annual costs of routine genotyping were US$1 569 525
and US$361 758 for the maternal and terminal lines, re-
spectively. Assuming a three-year planning horizon and a
5% discounting rate [4], the increased revenue for the ma-
ternal and terminal lines must be US$1 698 814.68 and
US$491 047.68, respectively, in order to break even on the
increased costs associated with incorporating genomic in-
formation into the selection program. Infrastructure costs
are relatively small compared to genotyping costs; there-
fore, the annual total cost and cost per weaned pig are
relatively insensitive to changes in the infrastructure costs.
Investments are routinely evaluated for their return on
investment, which in turn is often annualized in order to
evaluate yearly expenses relative to income. In the swine
industry, genetic companies will incur the costs associated
with genome-enabled selection. How genetic suppliers
market their animals will govern how the costs are recov-
ered. Some companies may sell boars or replacements
while other companies may receive royalties based on the
number of pigs weaned by their customers. For this study,
it was assumed that the genetic company making the in-
vestment in genome-enabled selection receives royalties
from weaned pigs at the commercial level.
Dividing the annualized costs by the number of semen
doses per year, results in costs of US$3.68 and US$0.18 per
dose in the maternal and terminal lines, respectively. To
calculate the cost per nucleus boar, the annualized cost was
divided by the number of boars used for commercial pro-
duction (male selection candidates × percent used). The
cost per nucleus boar was US$3052.13 and US$147.62 for
the maternal and terminal lines, respectively. Using the
total number of female pigs produced annually from the
maternal nucleus herds (1 940 845/2), it was determined
that genome-enabled selection costs would be approxi-
mately US$2.92 per nucleus daughter (F1 cross between
two maternal lines). This number was calculated from div-
iding the annualized costs by the number of productive
sows produced from the nucleus boars, accounting for the
gilt drop out percent. Assuming that each sow produced 35
weaned pigs in her lifetime, there is a US$0.083 cost per
weaned pig in the commercial production system for each
maternal line (US$2.92/35). The cost per weaned pig in thecommercial herd was determined to be US$0.047 for the
terminal line, assuming that 10 544 584 weaned pigs are
produced annually. This means that US$0.21 per weaned
pig from boars produced in the nucleus would need to be
added to the genetic merit for each market pig in order to
break even on the additional cost associated with genome-
enabled selection for all three lines. The marketing struc-
ture for the genetic supplier will determine how the add-
itional costs associated with genome-enabled selection can
or will be recovered from commercial sales.
The current rate of genetic gain in the nucleus will deter-
mine the proportional increase in rate of genetic gain
needed to recover genome-enabled selection costs. Accord-
ing to the National Swine Registry, the current rate of an-
nual genetic gain for their terminal line index is US$0.30,
US$0.40, and US$0.30 per weaned pig for the Duroc, Land-
race, and Large White populations, respectively [13]. The
traits, days to market, weight gained from weaned to
slaughter, and feed efficiency were included in the terminal
sire index [13]. The rate of genetic gain for number of born
alive is 0.08 and 0.07 pigs per year for Landrace and Large
White lines, respectively. Thus, the total annual genetic im-
provement for both maternal lines would be US$0.432 and
US$0.321 for the Landrace and Large White lines, respect-
ively. This rate of genetic gain may be lower than gains ex-
pected from most swine genetic companies. For each
maternal line, the total genetic improvement value is calcu-
lated by multiplying the terminal improvement by 1 plus
the increase in number of born alive ($0.40 × 1.08 for Land-
race, and $0.30 × 1.07 for Large White).
If the genetic supplier is part of an integrated system,
then the total genetic improvement from a maternal line
would be calculated as the terminal line improvement plus
the carcass value of the additional pigs born alive. This
would be $9.43 for Landrace and $8.20 for Large White
assuming 25% mortality from birth to finisher, 114 kg
market weight, and $1.32/kg market price. An integrated
producer could recover the costs of genome-enabled se-
lection by benefiting from improved production efficiency
in the commercial segment or by increasing retail prices
for the consumer while a genetic company would have to
recover the costs of genome-enabled selection by increas-
ing the premiums placed on their genetic product or by
increasing market share. The increased price must be jus-
tified by an increased rate of genetic gain. A commercial
producer will not necessarily pay for the full value of gen-
etic improvement it will receive. The genetic supplier will
only receive some percentage of the value of the improve-
ment made based on the incremental improvement in
genetic potential from one year to the next.
The current expected improvement in genetic merit at
the commercial level and the relative additional improve-
ment needed to pay for incorporating genome-enabled se-
lection into the breeding program are illustrated in
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improvement (US$0.15/weaned pig) in the Duroc line
would be passed on to the commercial herd and that the
cost estimate for genome-enabled selection in the terminal
line was US$0.044 per weaned pig, this would mean that a
31% improvement (US$0.047/US$0.15) in the genetic gain
rate would be needed to recover the genome-enabled selec-
tion costs. Considering this and the fact that 25% of the im-
provement occurring in each of the two maternal lines will
be passed on to the commercial animals, 77% (US$0.083/
US$0.108) and 104% (US$0.083/US$0.080) improvement in
genetic gain rate is needed for the Landrace and Large
White populations, respectively. Because of the planning
horizon used in this study and by most swine genetic com-
panies, these returns are based on one round of genetic im-
provement; however, differential genetic improvements
made with genome-enabled selection will be accumulated
over time.
These results reflect the necessary increase in genetic im-
provement at the nucleus level to break even on the esti-
mated genome-enabled selection costs provided that the
realized genetic improvement in commercial animals is
equivalent to the expected genetic improvement. Environ-
mental factors may reduce the realized genetic improve-
ment at the commercial levels compared to the expected
improvement based on predictions of genetic merit derived
from data recorded in the nucleus production environ-
ment. Greater nucleus level genetic improvement would be
required if all genetic improvement that occurs at the nu-
cleus population is not realized or does not actually occur
at the commercial production level.
Another way to recover the costs associated with
genome-enabled selection is through maintaining or cap-
turing increased market share. If a company must invest
in genome-enabled selection to maintain their currentFigure 1 Value of expected improvement in genetic merit at the com
genetic improvement published by the National Swine Registry for each of
using the values reported in this paper.market share, there must be some perceived marketing
value associated with incorporating genome-enabled selec-
tion into the breeding program. If a marketing value ex-
ists, the difference between the total costs associated with
genome-enabled selection per weaned pig and the market-
ing value is the increased value in genetic improvement
that must be achieved to break even on the investment in
genome-enabled selection. Thus, the necessary increase in
genetic improvement to break even would not be as large
as if the costs must be recovered through increasing gen-
etic potential alone.
Without increasing the nucleus herd size, the only way
to increase the market share is to increase the proportion
of male offspring produced in the nucleus herd that are
used to produce commercial piglets. The relationship be-
tween the proportion of nucleus boars used and propor-
tion of improvement in genetic gain rate for the terminal
and maternal lines are shown in Figures 2 and 3, respect-
ively. For example, if 80% of the male candidates in the
terminal line were used, compared to the 60% used in this
study, the proportional improvement in rate of genetic
gain needed to break even on the investment in genome-
enabled selection would be 22% compared to 29%. The
feasible region, or the region where the costs of genome-
enabled selection are recovered, is shaded in gray. The
gray area not on the break even line indicates that a profit
is made. For the results in Figure 2, it was assumed that
the current rate of genetic gain in the commercial animals
was US$0.15 per pig from the terminal line. The current
rate of genetic gain in the commercial animals was as-
sumed to be US$0.10 per pig from the maternal line for
the results in Figure 3.
The primary expected benefit from incorporating gen-
omic information into EBV estimation is improved accur-
acy [2]. Due to the direct relationship between accuracymercial level. Current rates of genetic improvement were based on
the three lines; the cost of genome-enabled selection was estimated
Figure 2 Feasible region for profitability when incorporating genome-enabled selection in a terminal line selection program.
The current annual rate of genetic improvement was assumed to be US$0.15 per commercial pig; the number of commercial pigs produced
from the nucleus boars was calculated using the values reported in the paper; the estimated cost of genome-enabled selection in the terminal
line was US$491 048; this number was estimated using the strategy in this paper.
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portionally increase the rate of genetic gain expected given
that selection intensity and generation interval remain
constant. This increase in accuracy will have to be suffi-
ciently large to recover the added costs associated with
using genomic information in the selection program.
Genome-enabled selection will not eliminate the need
for phenotype collection. Earlier theories associated with
genome-enabled selection suggested that one benefit
would be the cost savings associated with reducing or elim-
inating the collection of phenotypic data [14]; however,
due to the decay in accuracy associated with genomic
breeding values over generations, genomic breeding values
must be re-estimated periodically and phenotypic records
will be needed [15].
The application of genomic breeding values has been in-
vestigated for pig populations. Nielsen and coworkers
showed the correlation between genomic breeding values
and traditional BLUP breeding values to be 0.62 for the
170 boars used in their data set [14]. Cleveland and collab-
orators reported the accuracy of the genomic breeding
value for the total number of pigs born per litter to be be-
tween 0.64 and 0.82, depending on the initial dataset used
[16]. The authors reported that the accuracy of stillborns
per litter ranged from 0.33 to 0.68.Dekkers [17] developed a method using selection index
theory to calculate the genetic response expected from in-
corporating genomic information into a selection index.
The method deterministically calculated the genetic re-
sponse anticipated from using genomic selection with de-
fined genetic parameters. The study showed that, for a trait
recorded on both sexes prior to selection, selection based
on markers alone can improve response by 8.5% compared
to selection based only on phenotypic information. Based
on stochastic simulations, annual genetic gain could be in-
creased by 23 to 91% for a maternal line [5] and 27 to 33%
for a terminal line [16]. Based on these increases in annual
genetic gain, there is potential for genome-enabled selec-
tion to be profitable for both maternal and terminal line se-
lection programs. Under simulated conditions, MAS could
increase genetic improvement from selection for meat
quality, net or residual feed intake, and number of pigs
born alive compared to the response from traditional
BLUP. Under these simulated conditions, the largest
gap between marker-assisted selection and traditional
BLUP occurred for the meat quality traits; however, no
genetic improvement in rate of genetic gain was observed
for growth when comparing marker-assisted and trad-
itional BLUP selection methods under these simulated
conditions [1]. This suggests that the greatest potential for
Figure 3 Feasible region for profitability when incorporating genome-enabled selection in a maternal line selection program.
The current annual rate of genetic improvement was assumed to be US$0.10 per commercial pig; the number of commercial pigs produced
from the nucleus boars was calculated using the values reported in the paper; the estimated cost of genome-enabled selection in the terminal
line was US$1 698 815; this number was estimated using the strategy in this paper.
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enabled selection will be for lowly heritable traits that are
difficult to measure, sex limited, measured later in life or
measured after slaughter, such as meat quality, disease re-
sistance, feed efficiency, and longevity.
Disease resistance is not easily defined and not system-
atically measured. Feed efficiency is expensive to meas-
ure directly, especially on an individual animal basis.
Sow longevity is not recorded until the sow is culled
from the herd and is a trait that is only measured on fe-
males. If traits are not currently measured and recorded,
additional costs associated with measuring the novel
traits will be connected with genome-enabled selection
if these traits are targeted in a selection program. For a
novel trait to be incorporated into a selection program, a
measureable phenotype associated with the trait must be
clearly defined. Depending on the phenotype, there may
be a significant cost associated with the infrastructure
needed to collect the data.Conclusions
Using genomic information to estimate an animal’s genetic
merit at the molecular level can improve EBV accuracy
when compared to an EBV based only on phenotypicrecords. However, genome-enabled selection is expensive
and the increase in rate of genetic gain must be large
enough to offset the costs associated with incorporating
genome-enabled selection into a breeding program. A flexible
spreadsheet tool (accessible at the Iowa Pork Industry Center
website: http://www.ipic.iastate.edu/software.html) developed
from this work can be used to estimate the returns needed
to recover additional costs associated with genome-enabled
selection by modifying the input values such as herd size and
genotyping strategy to represent the specific design of any
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